Wolverine Trading
SLS icon

Wolverine Trading’s SELLAS Life Sciences SLS Stock Holding History

Wolverine Trading’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9
Closed -$5K – 5422
2017
Q3 		$5K Buy
+9
New +$5.94K ﹤0.01% 4327
2017
Q1 		– Sell
-8
Closed -$13.2K – 4922
2016
Q4 		$24K Buy
+8
New +$46.5K ﹤0.01% 4297

Other funds holding SLS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wolverine Trading's SLS Position: Q4 2017 in Review

Wolverine Trading sold out of SELLAS Life Sciences (SLS) in Q4 2017, closing a stake of 9 shares — an estimated $5K sold.

Wolverine Trading first reported a position in SLS in Q4 2016 and held it in 2 quarters. The position peaked at $24K in Q4 2016. 24 funds tracked by Wall St. Rank hold SLS as of Q4 2017.

  • Wolverine Trading reported no remaining SELLAS Life Sciences position as of Q4 2017 after selling out during the quarter.
  • Wolverine Trading sold 9 SELLAS Life Sciences shares in Q4 2017, an estimated $5K.
  • Wolverine Trading first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 2 quarters.
  • Wolverine Trading's SELLAS Life Sciences position peaked at $24K in Q4 2016.
  • 24 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2017.

Based on Wolverine Trading's 13F filing for Q4 2017, filed 14 Feb 2018.